Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) from USFDA, for the company's formulations manufacturing facility at Duvvada, Visakhapatnam (Vizag SEZ Plant 1- FTO 7), indicating closure of the audit.
As intimated earlier the facility has been classified as V AI (Voluntary Action Indicated).
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)